US 11104729
Anti-IL-33 antibodies and uses thereof
granted A61KA61K2039/505A61K39/3955
Quick answer
US patent 11104729 (Anti-IL-33 antibodies and uses thereof) held by REGENERON PHARMACEUTICALS, INC. expires Mon Aug 26 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Aug 31 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 26 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K2039/505, A61K39/3955, A61K45/06, A61P